Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

KIAA1429 Inhibitors

The chemical class of inhibitors that can influence the activity of KIAA1429 operates largely through indirect mechanisms, given the current understanding of these compounds. They interact with various components of the cellular methylation machinery, which can lead to a downstream effect on the methylation status of RNA, a key process that KIAA1429 is involved in. These chemicals target different aspects of methylation, either by acting as analogs that get incorporated into biological molecules and disrupt their normal function, by inhibiting enzymes responsible for adding or removing methyl groups, or by altering the availability of the universal methyl donor S-adenosylmethionine.

The diversity in the mechanisms by which these chemicals act is reflective of the complex nature of cellular methylation processes. Some of the listed compounds are known to inhibit DNA methyltransferases, which, while distinct from RNA methyltransferases, can lead to broad changes in the cellular methylation landscape and indirectly influence RNA methylation. Others target enzymes like FTO or histone methyltransferases, which signifies the interconnectedness of different methylation pathways in the cell. By influencing these pathways, these chemicals can indirectly modulate the function of proteins such as KIAA1429, which are a part of the RNA methylation machinery. The interplay between DNA methylation, histone modification, and RNA methylation is an area of active research, and these chemicals provide tools to dissect these complex relationships.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Meclofenamic Acid

644-62-2sc-211780
5 mg
$402.00
(0)

Previously identified as an inhibitor of FTO, an m6A demethylase; could indirectly affect m6A levels and subsequently influence KIAA1429-associated pathways.

1-Aminocyclopentanecarboxylic acid

52-52-8sc-202392
1 g
$23.00
(0)

An amino acid analog that can inhibit S-adenosylmethionine-dependent methyltransferases indirectly by reducing S-adenosylmethionine levels.

5′-Deoxy-5′-methylthioadenosine

2457-80-9sc-202427
50 mg
$122.00
1
(1)

A byproduct of polyamine biosynthesis that inhibits S-adenosylhomocysteine hydrolase, indirectly affecting methyltransferase activity.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

A DNA methyltransferase inhibitor that could cause global hypomethylation, possibly affecting RNA methylation patterns indirectly.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

Another DNA methyltransferase inhibitor that, by altering methylation patterns, might have an indirect effect on RNA methylation and KIAA1429-related functions.

Zebularine

3690-10-6sc-203315
sc-203315A
sc-203315B
10 mg
25 mg
100 mg
$129.00
$284.00
$1004.00
3
(1)

A cytidine analog that inhibits DNA methyltransferases and could potentially influence RNA methylation indirectly.

Histone Lysine Methyltransferase Inhibitor Inhibitor

935693-62-2 (free base)sc-202651
5 mg
$151.00
4
(1)

A histone lysine methyltransferase inhibitor that may have off-target effects influencing RNA methylation processes.

Epz004777

1338466-77-5sc-507560
100 mg
$575.00
(0)

A selective inhibitor of DOT1L, a histone methyltransferase, which might impact methylation signaling pathways affecting KIAA1429 functionality.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A ribonucleoside analog that incorporates into RNA and inhibits RNA methylation, indirectly affecting processes KIAA1429 is involved in.